Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,970.00
Ask: 1,972.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.102%)
Open: 1,977.00
High: 1,977.00
Low: 1,957.00
Prev. Close: 1,958.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Stocks Set To Open Lower Ahead Of US Non-Farm Payrolls

Fri, 08th Nov 2013 07:48

LONDON (Alliance News) - UK equities are called to follow Asian and US stock indices lower Friday as investors await much-anticipated US jobs market data.

Stocks worldwide were dragged lower Thursday after a report from the US Commerce Department showed stronger-than-expected US third-quarter GDP growth. The report revealed that US gross domestic product rose by 2.8% in the third-quarter, from a 2.5% increase in the second-quarter, coming in ahead of economist estimates of an increase of 2.0%.

The strong figure, by dismissing signs that the US economy had slowed down through the end of the third-quarter, was seen by many as increasing the likelihood that the Federal Reserve may taper its USD85 billion-per-month asset buying programme in December.

Investor focus Friday shifts towards the health of the US jobs markets. A stronger-than-expected nonfarm payrolls report for October is likely to further increase the chance that the Fed will curb its asset-buying scheme. The data, scheduled at 1330 GMT, is expected to come in at 125,000, from 148,000 in September.

Separate US reports on personal income and spending and consumer spending, also are expected at 1330 GMT, will also provide a clearer picture on whether the US economy is resilient enough to withstand an early start to stimulus tapering.

Positive Chinese data released overnight has largely been dismissed.

China's trade surplus more than doubled in October, boosted by a stronger-than-expected rebound in exports, data from the General Administration of Customs showed Friday, suggesting that the economic recovery is gaining traction. The trade surplus jumped to USD31.1 billion in October from USD15.21 billion in September. Economists expected an increase to USD23.9 billion.

The country's exports grew 5.6% year-on-year in October compared with forecast for a 3.2% rise. For September, overseas shipments had fallen 0.3%. Imports grew 7.6% annually, faster than the 7.4% increase in the previous month, however slightly missing expectations of a rise to 8.5%.

The positive data will encourage Chinese leaders, gathering in Beijing this weekend for a key Communist Party meeting, to accelerate efforts to unlock another wave of economic reforms.

Ahead of the London open, the Nikkei trades down 1%, with the Hang Seng down 0.7%.

In the US, Wall Street closed lower Thursday. The DJIA closed down 1%, the S&P closed down 1.3%, and the Nasdaq Composite closed down 1.9%.

IG is calling the FTSE 100 to open lower at approximately 6666.0 points.

The euro is set for another volatile day Friday, having been hit Thursday on the back of the European Central Bank's rate cut and strong US third-quarter GDP growth.

Standard and Poor's has slashed France's sovereign credit ratings by one notch to 'AA', citing weak economic prospects and fiscal policy constraints.

In the wake of the decision, EURUSD and EURJPY were knocked, said CitiFX Wire's Nishtha Asthana. "The overall reaction however, is still muted," Asthana added.

However, the euro has been boosted in the aftermath of a strong German trade report. Germany's total trade surplus rose to EUR20.4 billion in September, compared to expectations for an increase of EUR15.5 billion.

Ahead of the UK equity market open, the euro trades at USD1.3410, GBP1.6101 and JPY131.632.

In Friday's data calendar, UK goods and total trade balance numbers are scheduled for 0930 GMT.

There has been a number of corporate releases ahead of the London open Friday. Blue-chip Rolls-Royce has been joined by FTSE 250-listed Hikma Pharmaceuticals, Bovis Homes and Tullett Prebon, amongst others, in releasing interim management statements. Rentokil initial has provided a trading statement. Merlin Entertainment has announced its IPO price.

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more
27 Sep 2021 09:31

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

Read more
27 Sep 2021 09:28

UPDATE 2-Energy stocks, banks lift FTSE 100; Rolls-Royce top performer

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Rolls-Royce jumps on sales of Spain-based ITP, U.S. Air Force contract* Energy stocks track crude oil prices higher* Hikma Pharma gains o...

Read more
27 Sep 2021 08:50

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

Read more
27 Sep 2021 08:16

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

Read more
27 Sep 2021 07:49

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
13 Sep 2021 16:09

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
2 Sep 2021 09:38

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

Read more
27 Aug 2021 12:32

Hikma, Bio-Thera enter exclusive agreement for monoclonal antibody

(Sharecast News) - Bio-Thera Solutions and Hikma Pharmaceuticals have entered into a commercialisation and license agreement to commercialise a monoclonal antibody used for the treatment of Crohn's disease.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.